Clinical Trial Update: A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350 [Phase 2]

View source ↗

Summary

Phase 2 trial assessing long-term safety and efficacy of GDC-0853 in adults with moderate to severe rheumatoid arthritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GDC-0853

Snippet

Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2020-08-03